ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 112 filers reported holding ALBIREO PHARMA INC in Q3 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $960,694 | +98.5% | 44,303 | +77.5% | 0.00% | 0.0% |
| Q3 2022 | $484,000 | +14.2% | 24,962 | +17.0% | 0.00% | 0.0% |
| Q2 2022 | $424,000 | -30.0% | 21,330 | +5.1% | 0.00% | -33.3% |
| Q1 2022 | $606,000 | +156.8% | 20,300 | +100.0% | 0.00% | +200.0% |
| Q4 2021 | $236,000 | -21.1% | 10,150 | +5.8% | 0.00% | 0.0% |
| Q3 2021 | $299,000 | -11.5% | 9,596 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $338,000 | 0.0% | 9,596 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $338,000 | -8.6% | 9,596 | -2.8% | 0.00% | -50.0% |
| Q4 2020 | $370,000 | +12.5% | 9,869 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $329,000 | +26.1% | 9,869 | 0.0% | 0.00% | +100.0% |
| Q2 2020 | $261,000 | +29.2% | 9,869 | +24.1% | 0.00% | 0.0% |
| Q4 2019 | $202,000 | +0.5% | 7,951 | +27.7% | 0.00% | 0.0% |
| Q1 2019 | $201,000 | – | 6,225 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |